Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 12/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27517899 | 0.90 | TBXA2R (0.45) | TBXA2RFFAR1MGLLGAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL28218726 | 0.79 | GAA (0.47) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL28275004 | 0.79 | GAA (0.47) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL29395915 | 0.79 | GAA (0.47) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL56020 | 0.79 | GAA (0.47) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL56021 | 0.79 | GAA (0.47) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL23647500 | 0.78 | GAA (0.46) | TBXA2RFFAR1GAASMN1; SMN2 | |
| Cyhalofop-Butyl SCHEMBL28855506 | 0.78 | GAA (0.46) | TBXA2RFFAR1GAASMN1; SMN2 | |
| SCHEMBL5403728 | 0.78 | TBXA2R (0.46) | TBXA2RFFAR1 | |
| SCHEMBL10383518 | 0.77 | TBXA2R (0.45) | TBXA2RFFAR1MGLLGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2005-09-01 | — | — | US | claimed |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | BAYER CROPSCIENCE AG (GB) | 2005-04-28 | — | — | US | claimed |
| US-20040116294-A1 | Herbicides based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2004-06-17 | — | — | US | claimed |
| US-7202196-B2 | Selective herbicide comprising a tetrazolinone derivative | BAYER CROPSCIENCE AG (DE) | 2007-04-10 | — | — | US | disclosed |
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2005-09-01 | — | — | US | disclosed |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | BAYER CROPSCIENCE AG (GB) | 2005-04-28 | — | — | US | disclosed |
| US-20050085388-A1 | Selective herbicide comprising a tetrazolinone derivative | BAYER CROPSCIENCE AG (DE) | 2005-04-21 | — | — | US | disclosed |
| US-20040116294-A1 | Herbicides based on substituted aryl ketones | BAYER CROPSCIENCE AG (DE) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192182-A1 | Herbicidal mixtures based on substituted aryl ketones | DDT, CBR3, CYP1B1 | TBXA2R 4210/4885FFAR1 984/4885MGLL 344/4885 |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | DDT, CBR3, CBR1 | TBXA2R 3852/4885FFAR1 984/4885MGLL 476/4885 |
| US-20050085388-A1 | Selective herbicide comprising a tetrazolinone derivative | DDT, DYRK4, DYRK3 | TBXA2R 3159/4885FFAR1 2774/4885MGLL 670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.